NOTE PURCHASE AGREEMENT Dated as of October 1, 2021 among OSMOTICA PHARMACEUTICAL CORP., as the Issuer, OSMOTICA HOLDINGS US LLC, as Intermediate Holdings, OSMOTICA PHARMACEUTICALS PLC, as Super Holdings, CERTAIN SUBSIDIARIES OF SUPER HOLDINGS, as the...Note Purchase Agreement • October 6th, 2021 • Osmotica Pharmaceuticals PLC • Pharmaceutical preparations • New York
This NOTE PURCHASE AGREEMENT is entered into as of October 1, 2021 among OSMOTICA PHARMACEUTICAL CORP., a Delaware corporation (the “Issuer”), OSMOTICA HOLDINGS US LLC, a Delaware limited liability company (“Intermediate Holdings”), OSMOTICA PHARMACEUTICALS PLC, an Irish public limited company (“Super Holdings”), the Guarantors (defined herein), the Purchasers (defined herein) and ATHYRIUM OPPORTUNITIES IV ACQUISITION LP, as the Administrative Agent.
SHARE SUBSCRIPTION AGREEMENTShare Subscription Agreement • October 6th, 2021 • Osmotica Pharmaceuticals PLC • Pharmaceutical preparations • New York
This Share Subscription Agreement (this “Agreement”) is dated as of October 1, 2021 (the “Effective Date”), between Osmotica Pharmaceuticals plc, a public limited company incorporated under the laws of Ireland (the “Company”), and Athyrium Opportunities IV Acquisition 2 LP, a Delaware limited partnership (the “Purchaser”).
